CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Medivir B - MVIRb CFD

    6.88
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.72
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.019721 %
    Charges from borrowed part ($-0.79)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.019721%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.002501 %
    Charges from borrowed part ($-0.10)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.002501%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 SEK
    保证金 20%
    上市交易所 Sweden
    交易费 0%

    *Information provided by Capital.com

    Medivir AB ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* N/A
    开仓* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 6.92-10.52
    平均交易量（10 天） 23.22K
    平均交易量（3 个月) 572.28K
    市值 396.47M
    市盈率 -100.00K
    流通股 55.72M
    收入 4.31M
    EPS -1.35
    股息（收益率 %） N/A
    贝塔 0.68
    下一个财报发布日期 Aug 18, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    May 26, 2023 6.88 0.00 0.00% 6.88 6.88 6.88
    May 15, 2023 6.88 0.24 3.61% 6.64 6.88 6.64
    May 12, 2023 7.02 -0.14 -1.96% 7.16 7.16 7.02
    May 11, 2023 7.02 0.00 0.00% 7.02 7.02 7.02
    May 10, 2023 7.00 -0.02 -0.28% 7.02 7.02 7.00
    May 9, 2023 7.02 0.04 0.57% 6.98 7.02 6.98
    May 8, 2023 6.98 0.06 0.87% 6.92 6.98 6.92
    May 3, 2023 7.26 0.00 0.00% 7.26 7.26 7.26
    May 2, 2023 7.32 0.00 0.00% 7.32 7.32 7.32
    Apr 26, 2023 7.06 -0.18 -2.49% 7.24 7.24 7.00
    Apr 25, 2023 7.22 0.04 0.56% 7.18 7.26 7.18
    Apr 24, 2023 7.24 0.00 0.00% 7.24 7.28 7.24
    Apr 21, 2023 7.24 -0.04 -0.55% 7.28 7.28 7.24
    Apr 20, 2023 7.28 0.00 0.00% 7.28 7.28 7.28
    Apr 11, 2023 7.26 0.00 0.00% 7.26 7.26 7.26
    Mar 29, 2023 7.26 0.00 0.00% 7.26 7.26 7.26
    Mar 22, 2023 8.04 0.00 0.00% 8.04 8.04 8.04
    Mar 7, 2023 8.04 0.00 0.00% 8.04 8.04 8.04
    Feb 23, 2023 8.04 0.00 0.00% 8.04 8.04 8.04
    Feb 22, 2023 8.04 0.00 0.00% 8.04 8.04 8.04

    Medivir B Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Friday, August 18, 2023

    时间（协调世界时） (UTC)

    06:30

    国家/地区

    SE

    事件

    Q2 2023 Medivir AB Earnings Release
    Q2 2023 Medivir AB Earnings Release

    Forecast

    -

    Previous

    -
    Friday, November 3, 2023

    时间（协调世界时） (UTC)

    07:30

    国家/地区

    SE

    事件

    Q3 2023 Medivir AB Earnings Release
    Q3 2023 Medivir AB Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 4.408 25.538 13.948 8.724 23.863
    收入 4.408 25.538 13.948 8.724 23.863
    收入成本，共计 69.078 66.421 46.45 91.063 235.129
    毛利 -64.67 -40.883 -32.502 -82.339 -211.266
    总营业费用 91.762 87.656 56.848 134.703 374.893
    销售/一般/行政费用，总计 20.735 21.415 24.931 35.033 118.177
    研究与开发
    Depreciation / Amortization 2.571 2.595 4.43 7.085 24.532
    Other Operating Expenses, Total 0.632 -0.495 -16.318 1.522 -2.945
    营业收入 -87.354 -62.118 -42.9 -125.979 -351.03
    利息收入（费用），非经营净值 -1.411 -0.46 0.28 2.644 0.555
    税前净收入 -88.765 -62.579 -42.62 -123.334 -350.475
    税后净收入 -88.765 -63.125 -42.62 -123.44 -350.314
    未计算非常项目前的净收益 -88.765 -63.125 -42.62 -123.44 -350.314
    非常规项目总计
    净收入 -88.765 -63.125 -42.62 -123.44 -350.314
    普通股股东可获收益 (不含非经常性项目) -88.765 -63.125 -42.62 -123.44 -350.314
    普通股股东可获收益 (含非經常性項目) -88.765 -63.125 -42.62 -123.44 -350.314
    摊薄调整
    摊薄净收入 -88.765 -63.125 -42.62 -123.44 -350.314
    摊薄后加权平均股 55.736 52.815 29.5798 29.5798 29.1755
    扣除特别项目的每股摊薄盈利 -1.5926 -1.19521 -1.44085 -4.17311 -12.0071
    Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
    每股正常摊薄盈利 -1.59323 -1.20358 -1.48676 -4.17311 -12.0062
    异常费用（收入） -0.035 -0.68 -1.358 0 0
    Total Adjustments to Net Income
    其他，净值 -0.001 0.001
    利息费用（收入) - 净运营 -1.219 -1.6 -1.287
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0.4 2.308 1.1 0.5 0.5
    收入 0.4 2.308 1.1 0.5 0.5
    收入成本，共计 13.1 15.778 11.1 16.4 25.8
    毛利 -12.7 -13.47 -10 -15.9 -25.3
    总营业费用 20 20.962 15.7 22.6 32.5
    销售/一般/行政费用，总计 6.2 4.735 3.9 5.8 6.2
    Depreciation / Amortization 0.7 0.671 0.7 0.6 0.6
    Other Operating Expenses, Total 0 -0.222 0 -0.2 -0.1
    营业收入 -19.6 -18.654 -14.6 -22.1 -32
    利息收入（费用），非经营净值 0.7 0.489 -0.2 -1.1 -0.7
    税前净收入 -18.9 -18.065 -14.8 -23.1 -32.7
    税后净收入 -18.9 -18.065 -14.8 -23.1 -32.7
    未计算非常项目前的净收益 -18.9 -18.065 -14.8 -23.1 -32.7
    净收入 -18.9 -18.065 -14.8 -23.1 -32.7
    普通股股东可获收益 (不含非经常性项目) -18.9 -18.065 -14.8 -23.1 -32.7
    普通股股东可获收益 (含非經常性項目) -18.9 -18.065 -14.8 -23.1 -32.7
    摊薄净收入 -18.9 -18.065 -14.8 -23.1 -32.7
    摊薄后加权平均股 55.736 55.736 55.736 55 55.736
    扣除特别项目的每股摊薄盈利 -0.3391 -0.32412 -0.26554 -0.42 -0.58669
    Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
    每股正常摊薄盈利 -0.3391 -0.32412 -0.26554 -0.42 -0.58669
    其他，净值 0.1 0.1
    Total Adjustments to Net Income
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 123.044 225.917 78.931 152.811 311.64
    现金和短期投资 117.434 221.167 70.007 134.509 286.281
    Cash 6.448 14.69 14.038 34.3 47.175
    短期投资 110.986 206.477 55.969 100.209 239.106
    应收账款总额，净额 2.826 2.74 3.992 11.557 5.538
    Accounts Receivable - Trade, Net 0.001 0 0.015 0.063 0.159
    Total Inventory
    Prepaid Expenses 2.784 2.01 4.932 6.745 19.82
    Total Assets 234.197 335.825 191.462 293.462 419.352
    Property/Plant/Equipment, Total - Net 14.841 13.597 16.211 23.283 10.828
    Property/Plant/Equipment, Total - Gross 33.143 21.356 28.658 38.416 106.498
    Accumulated Depreciation, Total -18.302 -7.76 -12.447 -15.133 -95.67
    Goodwill, Net
    Intangibles, Net 96.312 96.312 96.32 96.341 96.885
    Other Long Term Assets, Total -0.001 -0.001
    Total Current Liabilities 28.009 41.716 34.67 54.974 96.983
    Accounts Payable 3.763 10.338 6.808 12.303 16.335
    Accrued Expenses 8.11 29.171 25.414 30.016 50.64
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 14.023 1.153 0.848 5.926 30.008
    Total Liabilities 41.408 54.679 49.557 109.006 111.746
    Total Long Term Debt 13.399 12.964 14.888 37.153 0
    Deferred Income Tax 0
    Total Equity 192.789 281.146 141.905 184.456 307.606
    Common Stock 27.868 27.868 188.494 188.494 188.494
    Additional Paid-In Capital 805.349 804.944 420.804 420.208 420.208
    Retained Earnings (Accumulated Deficit) -637.184 -548.419 -463.655 -421.035 -297.595
    Other Equity, Total -3.244 -3.247 -3.738 -3.211 -3.501
    Total Liabilities & Shareholders’ Equity 234.197 335.825 191.462 293.462 419.352
    Total Common Shares Outstanding 55.7242 55.7242 29.5796 29.5796 29.5797
    Other Current Assets, Total 0.001
    Other Liabilities, Total -0.001 -0.001 16.879 14.763
    Note Receivable - Long Term 0 0 21.027
    Current Port. of LT Debt/Capital Leases 2.113 1.054 1.6 6.729
    Capital Lease Obligations 13.399 12.964 14.888 37.153
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 105.7 123.044 147.5 168.2 185.7
    现金和短期投资 100.8 117.434 142.2 162.8 180.8
    Cash 4.9 6.448 7 4.6 4.8
    短期投资 95.9 110.986 135.2 158.2 176
    应收账款总额，净额 4.9 2.826 5.3 5.4 4.9
    Accounts Receivable - Trade, Net 4.9 0.001 5.3 5.4 4.9
    Total Assets 216.2 234.197 259.3 276.9 295
    Property/Plant/Equipment, Total - Net 14.1 14.841 15.5 12.4 13
    Intangibles, Net 96.3 96.312 96.3 96.3 96.3
    Note Receivable - Long Term
    Other Long Term Assets, Total 0.1
    Total Current Liabilities 29.4 28.009 33.9 39.5 34.1
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 29.4 1.46 33.9 39.5 34.1
    Total Liabilities 42.3 41.408 48.8 51.6 46.6
    Total Long Term Debt 12.8 13.399 14.9 12.1 12.5
    Capital Lease Obligations 12.8 13.399 14.9 12.1 12.5
    Total Equity 173.9 192.789 210.5 225.3 248.4
    Common Stock 27.9 27.868 27.9 27.9 27.9
    Additional Paid-In Capital 805.3 805.349 804.9 804.9 804.9
    Retained Earnings (Accumulated Deficit) -656.1 -637.184 -619.1 -604.3 -581.2
    Other Equity, Total -3.2 -3.244 -3.2 -3.2 -3.2
    Total Liabilities & Shareholders’ Equity 216.2 234.197 259.3 276.9 295
    Total Common Shares Outstanding 55.7246 55.7242 55.7246 55.7246 55.7246
    Prepaid Expenses 2.784
    Other Liabilities, Total 0.1
    Accounts Payable 3.763
    Accrued Expenses 20.673
    Current Port. of LT Debt/Capital Leases 2.113
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -88.765 -62.579 -42.62 -123.334 -350.475
    经营活动产生的现金 -101.82 -48.734 -58.053 -148.255 -318.63
    经营活动产生的现金 2.571 2.595 4.43 7.086 26.304
    非现金物品 0 -16.968 -18.293 30.583
    Cash Taxes Paid 0 1.214 -0.799 -1.946 -2.987
    已付现金利息 1.315 0.015
    营运资金的变化 -15.626 11.25 -2.895 -13.714 -25.042
    投资活动产生的现金 -0.382 0 5.368 4.49 -6.838
    资本支出 -0.382 0 -2.684 -1.436 -6.838
    其他投资现金流量项目，总计 0 8.052 5.926
    融资活动产生的现金 -1.535 199.4 -12.118 -6.659 143.79
    融资现金流项目 0.001 -24.115 -12.713 -6.659 -11.287
    股票的发行（报废），净额 0.404 223.515 0.595 0 155.077
    外汇效应 0.003 0.494 0.301 -1.349 0.18
    现金净变化 -103.734 151.16 -64.502 -151.773 -181.498
    债务的发行（退还），净额 -1.94
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Cash From Operating Activities -16.1 -101.82 -77.1 -57.5 -39.9
    Changes in Working Capital -16.1 -101.82 -77.1 -57.5 -39.9
    Cash From Investing Activities 0 -0.382 -0.4 0 0
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities -0.5 -1.535 -1.4 -1 -0.5
    Financing Cash Flow Items -0.5 0.001 -1.4 -1 -0.5
    Issuance (Retirement) of Stock, Net 0 0.404 0 0
    Foreign Exchange Effects 0 0.003 0 0 0
    Net Change in Cash -16.6 -103.734 -78.9 -58.5 -40.4
    Capital Expenditures 0 -0.382 -0.4 0 0
    Issuance (Retirement) of Debt, Net -1.94
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Julander (Bengt) Individual Investor 12.2493 6840172 0 2022-09-30 LOW
    Avanza Bank Holding AB Holding Company 10.57 5902425 308149 2022-09-30 LOW
    Nordea Funds Oy Investment Advisor 8.5515 4775296 -331344 2023-02-28 LOW
    Healthinvest Partners AB Investment Advisor/Hedge Fund 6.2857 3510000 0 2022-09-30 MED
    Nordnet Pensionsforsakring AB Corporation 2.8118 1570173 -262681 2022-09-30 LOW
    Ålandsbanken Asset Management Ab Investment Advisor 2.037 1137481 0 2022-09-30 LOW
    N.G.L. Förvaltning AB Corporation 1.7908 1000000 0 2022-09-30
    Bank Julius Bär & Co. AG Bank and Trust 1.5926 889350 0 2022-09-30 LOW
    Nydah (Jan Stefan) Individual Investor 1.3251 739954 0 2022-09-30
    SEB Investment Management AB Investment Advisor 1.1461 640000 0 2022-09-30 LOW
    Jonsson (Jonas Fredrik) Individual Investor 0.9226 515201 515201 2021-12-30
    Gryningskust Holding AB Corporation 0.8417 470000 0 2022-09-30
    Öberg (Bo) Individual Investor 0.8018 447744 0 2022-09-30
    Banque Pictet & Cie S.A. Investment Advisor 0.7178 400826 0 2022-09-30 LOW
    Hacksell (Uli) Individual Investor 0.4477 250000 100000 2021-12-30
    Öberg (Fredrik) Individual Investor 0.1239 69172 0 2021-12-30
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.0705 39360 -18355 2023-03-31 LOW
    Mahshid (Yilmaz Ph.D.) Individual Investor 0.0448 25000 0 2021-12-30
    Christensen (Magnus) Individual Investor 0.0376 21000 6000 2021-12-30
    Hansson (Lennart Ph.D.) Individual Investor 0.0358 20000 0 2021-12-30

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    530K+

    交易者

    87K+

    每月活跃客户

    $46M+

    每月投资额

    $31M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Medivir Company profile

    关于 Medivir B

    Medivir AB是一家总部设在瑞典的制药研究和开发公司，专注于肿瘤学。 公司专注于蛋白酶抑制剂的设计和核苷及核苷酸科学，并将其应用于未满足医疗需求的癌症的治疗方法的开发。 公司的临床管线包括治疗皮肤T细胞淋巴瘤（CTCL）的II期临床研究中的局部组蛋白去乙酰化酶（HDAC）抑制剂remetinostat，治疗实体瘤的I期临床研究中的birinapant与Keytruda（pembrolizumab）联合治疗。 MIV-818，一种基于核苷酸的原药，处于治疗肝癌的一期临床试验中，以及MIV-711，一种治疗骨关节炎的IIa扩展研究中的猫蛋白酶K（CTSK）抑制剂。 此外，公司还与其他机构合作开展了其他研究项目。

    Industry: Bio Therapeutic Drugs

    Lunastigen 5, 2 tr
    HUDDINGE
    STOCKHOLM 141 22
    SE

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.50 Price
    +2.290% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00373

    Gold

    1,949.51 Price
    +0.270% 1D Chg, %
    多头隔夜费 -0.0184%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    Oil - Crude

    71.15 Price
    -2.450% 1D Chg, %
    多头隔夜费 -0.0146%
    空头隔夜费 -0.0073%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    US100

    14,466.70 Price
    +0.590% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    还在找一位您可以信任的经纪商吗？

    加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易